Skip to main content
OpenTrials
Completed

NCT Number: NCT03789266

Drains Ablation Post Total Hip Arthroplasty : Search for the Least Painful Technique

Comparison of ablation technique of drains

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rouen University Hospital

Rouen, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients admitted to the orthopedic surgery department for surgery for a total hip arthroplasty
  • Signed inform consent form

Exclusion criteria

  • Drain in non-aspirating mode at the time of medical ablation prescription
  • Administration of analgesic III in the 12 hours preceding the inclusion

Treatment and study plan

drain ablation

Procedure

drain ablation will be done in Aspiration mode or in non Aspiration mode

Primary outcomes

  1. Evaluate the pain felt by the patients at the time of the removal of the drain, using the pain visual analogue scale

    Time frame: 20 minutes

    pain will be measured using a visual analogic scale from 0 (for no pain) to 10 (fo maximum pain)

Secondary outcomes

  1. Presence of haematoma after ablation

    Time frame: Day 2 post ablation

    Presence or absence of haematoma will be visually checked

Sponsors and collaborators

Lead sponsor

University Hospital, Rouen

Other

Registry information

Acronym: TADDA

Important dates

Study start
2018
Primary completion
2023
Study completion
2023
First posted
Dec 28, 2018
Registry last updated
Jun 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.